Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kalaris Therapeutics, Inc.

KLRS Clue Score19
United States Fiscal year ends December CIK 0001754068 Results filed 11 Aug 2026

What the insiders did Net buying

By person

25 insiders · 349 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Morana Jovan-Embiricos
Director
$49.30M (2)
$713.82K (14)
+$48.59M
19,574,963
$94.55M
—
Gilead Sciences, Inc. entity
10% owner
$10.99M (1)
—
+$10.99M
16,635,286
$80.35M
+21.4%
David Hallal
Director
—
$8.93M (8)
−$8.93M
3,019,968
$14.59M
—
Malcolm Brenner
Director
—
$7.34M (35)
−$7.34M
263,929
$1.27M
+36.1%
John Robert Wilson
Director
—
$6.27M (14)
−$6.27M
11,942,863
$57.68M
+80.7%
Srinivas Akkaraju
Director
$6.18M (2)
—
+$6.18M
19,408
$93.74K
—
Beek Jeroen B Van
Chief Commercial Officer
$51.00K (1)
$6.01M (43)
−$5.96M
333,726
$1.61M
−35.2%
Ann M. Leen
Chief Scientific Officer
—
$5.39M (22)
−$5.39M
4,721,302
$22.80M
+99.3%
Juan Vera
Director
—
$5.06M (25)
−$5.06M
2,409,928
$11.64M
+7,881%
Agustin Melian
Chief Medical Officer
—
$3.79M (11)
−$3.79M
453,529
$2.19M
−14.6%
Jeffrey S Bornstein
Director
$67.55K (2)
$832.12K (2)
−$764.57K
110,197
$532.25K
+264.9%
Brett R Hagen
Chief Accounting Officer
—
$724.91K (55)
−$724.91K
0
$0.00
—
Diana Brainard
Chief Executive Officer
$107.10K (1)
$676.35K (34)
−$569.25K
723,363
$3.49M
+7,353%
Edward Miller
General Counsel
—
$291.49K (29)
−$291.49K
578,435
$2.79M
+39.6%
Vikas Sinha
See Remarks
—
$232.90K (39)
−$232.90K
30,144,865
$145.60M
+128.7%
Ercem Atillasoy
See Remarks
$59.50K (1)
$116.72K (8)
−$57.22K
131,372
$634.53K
—
Ansbert Gadicke
Director
—
—
—
30,125,933
$145.51M
+124.0%
ElevateBio, LLC entity
Director
—
—
—
16,674,766
$80.54M
—
Redmile Group, LLC entity
10% owner
—
—
—
823,371
$3.98M
—
Napoleone Ferrara
Director
—
—
—
504,000
$2.43M
—
Samir Chandrakant Patel
Director
—
—
—
352,800
$1.70M
—
Cintia Piccina
Chief Commercial Officer
—
—
—
147,000
$710.01K
—
Shawn Tomasello
Director
—
—
—
70,000
$338.10K
—
Derek N. Adams
Director
—
—
—
70,000
$338.10K
—
Matthew Feinsod
Chief Medical Officer
—
—
—
4,030
$19.46K
—

No percentages here. This company's share count has moved by a factor of 4.7 over the window, from 5,043,357 to 23,804,981 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.